{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T17:49:26Z","timestamp":1782409766458,"version":"3.54.5"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"DOI":"10.1007\/s10822-026-00868-5","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T17:33:13Z","timestamp":1782408793000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Coumarin-based small molecules for diabetes management: rational design, computational studies, synthesis, and biological evaluation"],"prefix":"10.1007","volume":"40","author":[{"given":"Sakshi","family":"Attri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8332-8057","authenticated-orcid":false,"given":"Paranjeet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5472-1976","authenticated-orcid":false,"given":"Sanjeev Kumar","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pragati","family":"Silakari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjinder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravidarshdeep","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"868_CR1","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1080\/14756366.2021.2024526","volume":"37","author":"Y Pan","year":"2022","unstructured":"Pan Y, Liu T, Wang X, Sun J (2022) Research progress of coumarins and their derivatives in the treatment of diabetes. J Enzyme Inhib Med Chem 37:616\u2013628","journal-title":"J Enzyme Inhib Med Chem"},{"key":"868_CR2","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1111\/jphp.12774","volume":"69","author":"H Li","year":"2017","unstructured":"Li H, Yao Y, Li L (2017) Coumarins as potential antidiabetic agents. J Pharm Pharmacol 69:1253\u20131264","journal-title":"J Pharm Pharmacol"},{"key":"868_CR3","doi-asserted-by":"publisher","first-page":"117955142110420","DOI":"10.1177\/11795514211042023","volume":"14","author":"S Ran\u0111elovi\u0107","year":"2021","unstructured":"Ran\u0111elovi\u0107 S, Bipat R (2021) A review of coumarins and coumarin-related compounds for their potential antidiabetic effect. Clin Med Insights Endocrinol Diabetes 14:11795514211042024","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"key":"868_CR4","doi-asserted-by":"publisher","first-page":"2439113","DOI":"10.1080\/16583655.2024.2439113","volume":"19","author":"PR Sahu","year":"2025","unstructured":"Sahu PR, Tanty DK, Sahu SK (2025) Coumarin derivatives against diabetics: a systematic target-specific drug repurposing approach via molecular docking-dynamic simulation. J Taibah Univ Sci 19:2439113","journal-title":"J Taibah Univ Sci"},{"key":"868_CR5","doi-asserted-by":"publisher","first-page":"4216","DOI":"10.1007\/s12325-023-02612-z","volume":"40","author":"J Zhu","year":"2023","unstructured":"Zhu J, Zhou Y, Li Q, Wang G (2023) Cost-effectiveness of newer antidiabetic drugs as second-line treatment for type 2 diabetes: a systematic review. Adv Ther 40:4216\u20134235","journal-title":"Adv Ther"},{"key":"868_CR6","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S2221-1691(12)60032-X","volume":"2","author":"DK Patel","year":"2012","unstructured":"Patel DK, Prasad SK, Kumar R, Hemalatha S (2012) An overview on antidiabetic medicinal plants having insulin mimetic property. Asian Pac J Trop Biomed 2:320\u2013330","journal-title":"Asian Pac J Trop Biomed"},{"key":"868_CR7","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.3390\/ph15111329","volume":"15","author":"XF Wang","year":"2022","unstructured":"Wang XF et al (2022) The therapeutic potential of plant polysaccharides in metabolic diseases. Pharmaceuticals 15:1329","journal-title":"Pharmaceuticals"},{"key":"868_CR8","doi-asserted-by":"publisher","first-page":"9250007","DOI":"10.26599\/FSHW.2024.9250007","volume":"14","author":"X Chen","year":"2025","unstructured":"Chen X et al (2025) Dendrobium officinale polysaccharide attenuates type 2 diabetes in mice model by modulating gut microbiota and alleviating intestinal mucosal barrier damage. Food Sci Hum Wellness 14:9250007","journal-title":"Food Sci Hum Wellness"},{"key":"868_CR9","doi-asserted-by":"publisher","first-page":"10121","DOI":"10.1039\/D2FO02300H","volume":"13","author":"X Chen","year":"2022","unstructured":"Chen X, Chen C, Fu X (2022) Hypoglycemic effect of the polysaccharides from Astragalus membranaceus on type 2 diabetic mice based on the \u201cgut microbiota\u2013mucosal barrier.\u201d Food Funct 13:10121\u201310133","journal-title":"Food Funct"},{"key":"868_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxrep.2025.101991","volume":"14","author":"S Kar","year":"2025","unstructured":"Kar S et al (2025) Evaluation of toxicity and anti-amylase activity of 7, 8 dihydroxy coumarin (Daphnetin), a novel \u03b1-amylase blocker in vitro and in vivo. Toxicol Rep 14:101991","journal-title":"Toxicol Rep"},{"key":"868_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2026.109482","volume":"170","author":"F Peytam","year":"2026","unstructured":"Peytam F et al (2026) Design, synthesis, and antidiabetic evaluation of triazolopyrimidine thioacetamides as potent and selective \u03b1-glucosidase inhibitors. Bioorg Chem 170:109482","journal-title":"Bioorg Chem"},{"key":"868_CR12","doi-asserted-by":"publisher","DOI":"10.47750\/PNR.2022.13.S05.114","author":"AA Husain","year":"2022","unstructured":"Husain AA et al (2022) An overview of natural and synthetic coumarin derivatives as potential antidiabetic agents. J Pharm Negat Results. https:\/\/doi.org\/10.47750\/PNR.2022.13.S05.114","journal-title":"J Pharm Negat Results"},{"key":"868_CR13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.52756\/BHSTIID.2025.E02.011","volume":"2","author":"B Sarkar","year":"2025","unstructured":"Sarkar B et al (2025) Pharmacological uses of new bioactive compounds from medicinal plants. Basic Handb Sci Technol Innov Incl Dev 2:131\u2013171. https:\/\/doi.org\/10.52756\/BHSTIID.2025.E02.011","journal-title":"Basic Handb Sci Technol Innov Incl Dev"},{"key":"868_CR14","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","volume":"83","author":"DJ Newman","year":"2020","unstructured":"Newman DJ, Cragg GM (2020) Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019. J Nat Prod 83:770\u2013803","journal-title":"J Nat Prod"},{"key":"868_CR15","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.gce.2023.04.003","volume":"5","author":"Y Zou","year":"2024","unstructured":"Zou Y, Teng Y, Li J, Yan Y (2024) Recent advances in the biosynthesis of coumarin and its derivatives. Green Chem Eng 5:150\u2013154","journal-title":"Green Chem Eng"},{"key":"868_CR16","doi-asserted-by":"publisher","first-page":"963248","DOI":"10.1155\/2013\/963248","volume":"2013","author":"KN Venugopala","year":"2013","unstructured":"Venugopala KN, Rashmi V, Odhav B (2013) Review on natural coumarin lead compounds for their pharmacological activity. Biomed Res Int 2013:963248","journal-title":"Biomed Res Int"},{"key":"868_CR17","doi-asserted-by":"publisher","first-page":"134","DOI":"10.2174\/1389557519666190925162536","volume":"20","author":"TB Tafesse","year":"2020","unstructured":"Tafesse TB et al (2020) Coumarin-based Scaffold as \u03b1-glucosidase inhibitory activity: implication for the development of potent antidiabetic agents. Mini Rev Med Chem 20:134\u2013151","journal-title":"Mini Rev Med Chem"},{"key":"868_CR18","unstructured":"A comprehensive review on pharmacological properties of coumarins\u202f\u00bb IJBBR. https:\/\/journals.stmjournals.com\/ijbbr\/article=2024\/view=190713\/?form=MG0AV3."},{"key":"868_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0348140","volume":"21","author":"I Zghab","year":"2026","unstructured":"Zghab I et al (2026) Hydrazone-schiff base derivatives of 4-(tert-butyl)benzoic acid as potent enzyme inhibitors: In vitro \u03b1-amylase, \u03b1-glucosidase, tyrosinase inhibition and computational studies. PLoS ONE 21:e0348140","journal-title":"PLoS ONE"},{"key":"868_CR20","doi-asserted-by":"publisher","first-page":"11005","DOI":"10.1039\/D5RA03358F","volume":"16","author":"M Ayaz","year":"2026","unstructured":"Ayaz M et al (2026) Exploring the anti-diabetic potential of bis-Schiff bases of ibuprofen: insights into the in vitro, molecular docking and density functional theory analyses. RSC Adv 16:11005\u201311022","journal-title":"RSC Adv"},{"key":"868_CR21","doi-asserted-by":"publisher","first-page":"e02383","DOI":"10.1002\/cbdv.202502383","volume":"23","author":"H Khan","year":"2026","unstructured":"Khan H et al (2026) Design, synthesis, computational studies, and antidiabetic evaluation of hydrazide derivative in vitro, in vivo and in silico investigation. Chem Biodivers 23:e02383","journal-title":"Chem Biodivers"},{"key":"868_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiolchem.2026.108977","volume":"123","author":"S Muhammad","year":"2026","unstructured":"Muhammad S et al (2026) Synthesis, in-vitro and in-silico studies of ether linked polyhydroquinoline derivatives for the management of diabetes mellitus. Comput Biol Chem 123:108977","journal-title":"Comput Biol Chem"},{"key":"868_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2025.143439","volume":"1348","author":"W Khan","year":"2025","unstructured":"Khan W et al (2025) Synthesis, \u03b1-amylase inhibition, molecular docking, and density functional theory analysis of N-benzylidene-2-(thiophene-2-carbonyl)hydrazine-1-carbothioamide derivatives. J Mol Struct 1348:143439","journal-title":"J Mol Struct"},{"key":"868_CR24","doi-asserted-by":"crossref","unstructured":"Sharma D, Ghosh P, Dhir R, Asati V (2026) Structural aspects of coumarin-heterocycle conjugates: a new frontier in antidiabetic drug discovery. Mini Rev. Med. Chem. 26","DOI":"10.2174\/0113895575454643260402035823"},{"key":"868_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.157339","volume":"148","author":"S Khatoon","year":"2025","unstructured":"Khatoon S et al (2025) Natural coumarins as anti-diabetic agents: Mechanisms, therapeutic potential, and amelioration of diabetic complications. Phytomedicine 148:157339","journal-title":"Phytomedicine"},{"key":"868_CR26","doi-asserted-by":"publisher","first-page":"E15701638374546","DOI":"10.2174\/0115701638374546250323152450","volume":"22","author":"S Singh","year":"2025","unstructured":"Singh S, Kaushik N, Paliwal A, Sengar MS, Paliwal D (2025) Biological activity and therapeutic potential of coumarin derivatives: a comprehensive review. Curr Drug Discov Technol 22:E15701638374546","journal-title":"Curr Drug Discov Technol"},{"key":"868_CR27","doi-asserted-by":"publisher","first-page":"956","DOI":"10.2174\/0115734064361520250115090651","volume":"21","author":"P Yadav","year":"2025","unstructured":"Yadav P, Shah K (2025) Recent advancements in the synthetic chemistry of oxazole derivatives and their significant medicinal applications. Med Chem 21:956\u2013968","journal-title":"Med Chem"},{"key":"868_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.rechem.2024.101638","volume":"9","author":"R Hussain","year":"2024","unstructured":"Hussain R et al (2024) Design, synthesis and in vitro biological evaluation of new coumarin containing oxazole hybrid derivatives as multitarget inhibitor of \u03b1-amylase and \u03b1-glucosidase for the treatment of diabetes. Results Chem 9:101638","journal-title":"Results Chem"},{"key":"868_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e05290","volume":"6","author":"V Channa Basappa","year":"2020","unstructured":"Channa Basappa V et al (2020) Design and synthesis of coumarin-triazole hybrids: biocompatible anti-diabetic agents, in silico molecular docking and ADME screening. Heliyon 6:e05290","journal-title":"Heliyon"},{"key":"868_CR30","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1021\/ed500324w","volume":"91","author":"KC Wong","year":"2014","unstructured":"Wong KC (2014) Review of NMR spectroscopy: basic principles, concepts and applications in chemistry. J Chem Educ 91:1103\u20131104","journal-title":"J Chem Educ"},{"key":"868_CR31","doi-asserted-by":"publisher","unstructured":"Human Pancreatic alpha-amylase in complex with myricetin (2012) https:\/\/doi.org\/10.2210\/PDB4GQR\/PDB","DOI":"10.2210\/PDB4GQR\/PDB"},{"key":"868_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241210195","author":"GA Mohamed","year":"2023","unstructured":"Mohamed GA, Omar AM, El-Araby ME, Mass S, Ibrahim SRM (2023) Assessments of alpha-amylase inhibitory potential of Tagetes flavonoids through in vitro, molecular docking, and molecular dynamics simulation studies. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241210195","journal-title":"Int J Mol Sci"},{"key":"868_CR33","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM et al (2009) AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem 30:2785\u20132791","journal-title":"J Comput Chem"},{"key":"868_CR34","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455\u2013461","journal-title":"J Comput Chem"},{"key":"868_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2021.116464","volume":"51","author":"N Foloppe","year":"2021","unstructured":"Foloppe N, Chen IJ (2021) The reorganization energy of compounds upon binding to proteins, from dynamic and solvated bound and unbound states. Bioorg Med Chem 51:116464","journal-title":"Bioorg Med Chem"},{"key":"868_CR36","first-page":"22","volume":"2","author":"U Baroroh","year":"2023","unstructured":"Baroroh U, Si S, Biotek M, Muscifa ZS, Destiarani W, Rohmatullah FG, Yusuf M (2023) Molecular interaction analysis and visualization of protein-ligand docking using biovia discovery studio visualizer. Indones J Comput Biol IJCB 2:22\u201330","journal-title":"Indones J Comput Biol IJCB"},{"key":"868_CR37","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3390\/pharmaceutics16010047","volume":"16","author":"W Weitschies","year":"2023","unstructured":"Weitschies W, Ong KH, Asano D, Takakusa H, Nakai D (2023) Oral absorption of middle-to-large molecules and its improvement, with a focus on new modality drugs. Pharmaceutics 16:47","journal-title":"Pharmaceutics"},{"key":"868_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-801559-9.00006-5","author":"V Mandlik","year":"2016","unstructured":"Mandlik V, Bejugam PR, Singh S (2016) Application of artificial neural networks in modern drug discovery. Artif Neural Netw Drug Des Deliv Dispos. https:\/\/doi.org\/10.1016\/B978-0-12-801559-9.00006-5","journal-title":"Artif Neural Netw Drug Des Deliv Dispos"},{"key":"868_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46:3\u201326","journal-title":"Adv Drug Deliv Rev"},{"key":"868_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2022.103344","volume":"28","author":"S Stegemann","year":"2023","unstructured":"Stegemann S et al (2023) Trends in oral small-molecule drug discovery and product development based on product launches before and after the rule of five. Drug Discov Today 28:103344","journal-title":"Drug Discov Today"},{"key":"868_CR41","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1038\/nprot.2014.110","volume":"9","author":"MJ Baker","year":"2014","unstructured":"Baker MJ et al (2014) Using Fourier transform IR spectroscopy to analyze biological materials. Nat Protoc 9:1771\u20131791","journal-title":"Nat Protoc"},{"key":"868_CR42","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.neuron.2018.08.011","volume":"99","author":"SA Hollingsworth","year":"2018","unstructured":"Hollingsworth SA, Dror RO (2018) Molecular dynamics simulation for all. Neuron 99:1129\u20131143","journal-title":"Neuron"},{"key":"868_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13321-025-01011-6","volume":"17","author":"D Errington","year":"2025","unstructured":"Errington D, Schneider C, Bouysset C, Dreyer FA (2025) Assessing interaction recovery of predicted protein-ligand poses. J Cheminform 17:1\u201313","journal-title":"J Cheminform"},{"key":"868_CR44","doi-asserted-by":"publisher","DOI":"10.1007\/S11030-025-11180-Z","author":"MAMA Reheim","year":"2025","unstructured":"Reheim MAMA et al (2025) Bioactivity of novel isoxazole-fused heterocycles: comprehensive antimicrobial, antioxidant activities, SwissADME predictions, molecular docking, and DFT analysis. Mol Divers. https:\/\/doi.org\/10.1007\/S11030-025-11180-Z","journal-title":"Mol Divers"},{"key":"868_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2025.144177","volume":"1351","author":"H Sarfraz","year":"2026","unstructured":"Sarfraz H et al (2026) Discovery and optimization of a novel series of pyrazole-linked oxadiazole conjugates as \u03b1-amylase inhibitors: In-silico DFT, ADMET-prediction, Toxicological assessment and molecular docking insight. J Mol Struct 1351:144177","journal-title":"J Mol Struct"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-026-00868-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-026-00868-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-026-00868-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T17:33:16Z","timestamp":1782408796000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-026-00868-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["868"],"URL":"https:\/\/doi.org\/10.1007\/s10822-026-00868-5","relation":{},"ISSN":["1573-4951"],"issn-type":[{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"6 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not Applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"161"}}